William Blair Cuts Earnings Estimates for DENTSPLY SIRONA

Key Points

• The earnings estimates for DENTSPLY SIRONA's Q3 2025 have been cut by William Blair, now forecasting $0.47 per share, down from a previous estimate of $0.49.
• Multiple analysts have downgraded their ratings and price targets for DENTSPLY SIRONA, with a current consensus rating of "Hold" and an average target price of $18.64.
• DENTSPLY SIRONA declared a quarterly dividend of $0.16, effective October 10th, which results in an annual yield of 4.9%.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Equities researchers at William Blair cut their Q3 2025 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a report issued on Thursday, August 7th. William Blair analyst B. Vazquez now anticipates that the medical instruments supplier will post earnings of $0.47 per share for the quarter, down from their previous forecast of $0.49. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA's Q4 2025 earnings at $0.46 EPS, FY2025 earnings at $1.88 EPS, Q1 2026 earnings at $0.46 EPS, Q2 2026 earnings at $0.55 EPS, Q3 2026 earnings at $0.50 EPS and FY2026 earnings at $2.01 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The company's revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.49 EPS.

XRAY has been the topic of several other research reports. Piper Sandler decreased their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. UBS Group decreased their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday, August 8th. Finally, Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Friday, August 8th. Twelve investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA has an average rating of "Hold" and a consensus target price of $18.64.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY traded down $0.16 during trading on Monday, hitting $13.70. 1,401,457 shares of the stock were exchanged, compared to its average volume of 2,999,124. DENTSPLY SIRONA has a 1-year low of $12.16 and a 1-year high of $27.48. The company has a market capitalization of $2.73 billion, a price-to-earnings ratio of -2.89, a price-to-earnings-growth ratio of 0.81 and a beta of 0.94. The company's fifty day simple moving average is $15.54 and its 200-day simple moving average is $15.79. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.7%. DENTSPLY SIRONA's payout ratio is currently -13.50%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Marathon Capital Management bought a new stake in DENTSPLY SIRONA in the second quarter valued at about $406,000. RBF Capital LLC bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth about $3,176,000. Qube Research & Technologies Ltd increased its holdings in shares of DENTSPLY SIRONA by 28.7% in the second quarter. Qube Research & Technologies Ltd now owns 2,044,651 shares of the medical instruments supplier's stock worth $32,469,000 after acquiring an additional 456,324 shares in the last quarter. iSAM Funds UK Ltd bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth about $660,000. Finally, AXA S.A. increased its holdings in shares of DENTSPLY SIRONA by 11.7% in the second quarter. AXA S.A. now owns 326,356 shares of the medical instruments supplier's stock worth $5,183,000 after acquiring an additional 34,161 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.